310 related articles for article (PubMed ID: 17629751)
1. The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy.
Tassinari D; Montanari L; Maltoni M; Ballardini M; Piancastelli A; Musi M; Porzio G; Minotti V; Caraceni A; Poggi B; Stella A; Aielli F; Scarpi E
Support Care Cancer; 2008 Apr; 16(4):359-70. PubMed ID: 17629751
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer.
Glare PA; Eychmueller S; McMahon P
J Clin Oncol; 2004 Dec; 22(23):4823-8. PubMed ID: 15570085
[TBL] [Abstract][Full Text] [Related]
3. Survival prediction for advanced cancer patients in the real world: A comparison of the Palliative Prognostic Score, Delirium-Palliative Prognostic Score, Palliative Prognostic Index and modified Prognosis in Palliative Care Study predictor model.
Baba M; Maeda I; Morita T; Inoue S; Ikenaga M; Matsumoto Y; Sekine R; Yamaguchi T; Hirohashi T; Tajima T; Tatara R; Watanabe H; Otani H; Takigawa C; Matsuda Y; Nagaoka H; Mori M; Tei Y; Hiramoto S; Suga A; Kinoshita H
Eur J Cancer; 2015 Aug; 51(12):1618-29. PubMed ID: 26074396
[TBL] [Abstract][Full Text] [Related]
4. Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.
Narducci F; Grande R; Mentuccia L; Trapasso T; Sperduti I; Magnolfi E; Fariello AM; Gemma D; Gamucci T
Support Care Cancer; 2012 Jun; 20(6):1221-6. PubMed ID: 21688165
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Koch A; Fohlin H; Sörenson S
J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non-small-cell Lung Cancer.
McGee SF; Zhang T; Jonker H; Laurie SA; Goss G; Nicholas G; Albaimani K; Wheatley-Price P
Clin Lung Cancer; 2018 Jan; 19(1):e91-e99. PubMed ID: 28666762
[TBL] [Abstract][Full Text] [Related]
7. Survival Prediction in Ambulatory Patients With Stage III/IV Non-Small Cell Lung Cancer Using the Palliative Performance Scale, ECOG, and Lung Cancer Symptom Scale.
O'Mahony S; Nathan S; Mohajer R; Bonomi P; Batus M; Fidler MJ; Wells K; Kern N; Sims S; Amin D
Am J Hosp Palliat Care; 2016 May; 33(4):374-80. PubMed ID: 25670717
[TBL] [Abstract][Full Text] [Related]
8. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.
Brule SY; Al-Baimani K; Jonker H; Zhang T; Nicholas G; Goss G; Laurie SA; Wheatley-Price P
Lung Cancer; 2016 Jul; 97():15-21. PubMed ID: 27237022
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with patient-reported subjective well-being among advanced lung or non-colonic gastrointestinal cancer patients.
Yennurajalingam S; Kim YJ; Zhang Y; Park J; Arthur J; Chisholm GB; Williams JL; Bruera E
Palliat Support Care; 2018 Feb; 16(1):23-31. PubMed ID: 28264748
[TBL] [Abstract][Full Text] [Related]
10. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
[TBL] [Abstract][Full Text] [Related]
11. A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer.
Rades D; Käsmann L; Schild SE; Janssen S
Clin Lung Cancer; 2016 Nov; 17(6):558-562. PubMed ID: 27341791
[TBL] [Abstract][Full Text] [Related]
12. Prognostic score for second-line chemotherapy of advanced non-small-cell lung cancer: external validation in a phase III trial comparing vinflunine with docetaxel.
Di Maio M; Krzakowski M; Fougeray R; Kowalski DM; Gridelli C
Lung Cancer; 2012 Jul; 77(1):116-20. PubMed ID: 22361218
[TBL] [Abstract][Full Text] [Related]
13. Identifying prognostic factors for survival in advanced cancer patients: a prospective study.
Lam PT; Leung MW; Tse CY
Hong Kong Med J; 2007 Dec; 13(6):453-9. PubMed ID: 18057434
[TBL] [Abstract][Full Text] [Related]
14. Clinician prediction of survival versus the Palliative Prognostic Score: Which approach is more accurate?
Hui D; Park M; Liu D; Paiva CE; Suh SY; Morita T; Bruera E
Eur J Cancer; 2016 Sep; 64():89-95. PubMed ID: 27372208
[TBL] [Abstract][Full Text] [Related]
15. Development of a predicting tool for survival of terminally ill cancer patients.
Hyodo I; Morita T; Adachi I; Shima Y; Yoshizawa A; Hiraga K
Jpn J Clin Oncol; 2010 May; 40(5):442-8. PubMed ID: 20085908
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models.
Nieder C; Kämpe TA
Anticancer Res; 2018 Mar; 38(3):1705-1709. PubMed ID: 29491105
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
Paesmans M; Sculier JP; Libert P; Bureau G; Dabouis G; Thiriaux J; Michel J; Van Cutsem O; Sergysels R; Mommen P
J Clin Oncol; 1995 May; 13(5):1221-30. PubMed ID: 7738625
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of gefitinib antitumor activity in East Asian advanced non-small cell lung cancer patients.
Chang GC; Tsai CM; Chen KC; Yu CJ; Shih JY; Yang TY; Lin CP; Hsu JY; Chiu CH; Perng RP; Yang PC; Yang CH
J Thorac Oncol; 2006 Jul; 1(6):520-5. PubMed ID: 17409911
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors associated with interventional bronchoscopy in lung cancer.
Guibert N; Mazieres J; Lepage B; Plat G; Didier A; Hermant C
Ann Thorac Surg; 2014 Jan; 97(1):253-9. PubMed ID: 24094520
[TBL] [Abstract][Full Text] [Related]
20. Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.
Pentheroudakis G; Fountzilas G; Kalofonos HP; Golfinopoulos V; Aravantinos G; Bafaloukos D; Papakostas P; Pectasides D; Christodoulou C; Syrigos K; Economopoulos T; Pavlidis N;
Crit Rev Oncol Hematol; 2008 Jun; 66(3):237-47. PubMed ID: 18243010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
